Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Nuchal translucency measurement in fetuses with spinal muscular atrophy.

Prenatal diagnosis - 1 Apr 2011

Zadeh Neda, Hudgins Louanne, Norton Mary E

Abstract excerpt

OBJECTIVE: Spinal muscular atrophy (SMA) is an autosomal recessive neurodegenerative disorder with a high carrier frequency in the general population. The severity of this disorder indicates the importance of early prenatal detection. In medical literature, there are a few published case reports of enlarged nuchal translucency (NT) measurement in association with a diagnosis of SMA in the fetus. Our goal is to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fetus
Share to Gestational Age
Share to Infant, Newborn

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Muscular Atrophy, Spinal

Share to Phenotype

Share to Pregnancy

Share to Pregnancy Trimester, First

Share to Ultrasonography, Prenatal

Source

Identifiers

PMID: 21287566
DOI: 10.1002/pd.2646

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Nuchal translucency measurement in fetuses with spinal muscular atrophy.PMID 21287566Read ↗

The first registered type 0 spinal muscular atrophy patient in Latvia: call for change in prenatal diagnostic procedures, case reportSemantic proximity Read ↗

Evaluation of fetal nuchal translucency in 98 pregnancies at risk for severe spinal muscular atrophy: possible relevance of the SMN2 copy number.Semantic proximity Read ↗

Type 0 Spinal Muscular Atrophy: Further Delineation of Prenatal and Postnatal Features in 16 Patients.Semantic proximity Read ↗

Outcome of fetuses with enlarged nuchal translucency and normal karyotypeSemantic proximity Read ↗

Prenatal Carrier Screening for Spinal Muscular AtrophySemantic proximity Read ↗

Transmission ratio distortion in the spinal muscular atrophy locus: data from 314 prenatal tests.Semantic proximity Read ↗

Increased nuchal translucency and normal karyotype: perinatal and pediatric outcomes at 2 years of ageSemantic proximity Read ↗

Nuchal translucency measurement in normal fetusesSemantic proximity Read ↗

Prenatal onset spinal muscular atrophy.Semantic proximity Read ↗

Increased nuchal translucency as a prenatal manifestation of congenital adrenal hyperplasia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.